Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
15
Recruiting, any sponsor type, condition "opioid dependence"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed248
15 trials
Showing 1 to 15, recently updated first.
- VK4-116 Phase I Study With Food-EffectRecruiting
National Institute on Drug Abuse (NIDA)NIH
NCT06808932 · 48 participants (planned) · Start Sep 25, 2026 · Primary completion Jul 2027
Drug: VK4-116; Placebo · For: Opioid Dependence; Opioid Use Disorder (OUD)
Sites: Overland Park, Kansas
- Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid HemorrhageRecruiting
The University of Texas Medical Branch, GalvestonAcademic, hospital or other
NCT07294118 · 15 participants (planned) · Start Jan 2, 2026 · Primary completion Jun 2027
Drug: Lidocaine; Lidocaine and Dexamethasone · For: Subarachnoid Hemorrhage, Aneurysmal; Headache; Opiate Dependence and 1 more
Sites: Galveston, Texas
Adneuris Therapeutics, Inc.Industry
NCT07874620 · 45 participants (planned) · Start Oct 2026 · Primary completion Mar 2027
Drug: Cebranopadol; Cebranopadol and 1 more · For: Chronic Pain; Pain; Opioid Withdrawal (Disorder) and 1 more
Sites: North Canton, Ohio; Houston, Texas
- MethaLoad Dose-Finding StudyRecruiting
Ashish P Thakrar, MD MSAcademic, hospital or other
NCT06877858 · 24 participants (planned) · Start Sep 25, 2025 · Primary completion Dec 31, 2027
Drug: Methadone hydrochloride · For: Opioid Use Disorder (OUD)
Sites: Philadelphia, Pennsylvania
- Combined THC and CBD for OUD and Chronic PainPivotal-lookingRecruiting
Yale UniversityAcademic, hospital or other
NCT06544291 · 147 participants (planned) · Start Oct 22, 2024 · Primary completion Jan 28, 2028
Drug: CBD 300mg; CBD 600mg and 1 more · For: Chronic Pain; Opioid Use Disorder
Sites: New Haven, Connecticut
University of PennsylvaniaAcademic, hospital or other
NCT06379984 · 60 participants (planned) · Start May 8, 2025 · Primary completion Dec 31, 2026
Drug: Buprenorphine · For: Opioid Use Disorder
Sites: Philadelphia, Pennsylvania
- Measuring Acute Drug Demand in HumansRecruiting
University of Maryland, BaltimoreAcademic, hospital or other
NCT05829655 · 75 participants (planned) · Start Aug 8, 2023 · Primary completion Jan 1, 2028
Drug: Drug A (Blinded Drug); Drug B (Blinded Drug) and 4 more · For: Opioid Use Disorder; Opioid Dependence
Sites: Baltimore, Maryland
- Better Options for Chronic Cancer PainPivotal-lookingRecruiting
VA Office of Research and DevelopmentFederal agency
NCT06574009 · 294 participants (planned) · Start Oct 7, 2025 · Primary completion Apr 1, 2029
Drug: Medication optimization · For: Chronic Pain; Cancer Survivor; Opioid Dependence
Sites: Indianapolis, Indiana; Ann Arbor, Michigan
University of CalgaryAcademic, hospital or other
NCT04939623 · 40 participants (planned) · Start Oct 31, 2023 · Primary completion Dec 31, 2026
Drug: Probenecid · For: Chronic Pain; Drug Dependence of Morphine Type; Symptom, Withdrawal
Sites: Calgary, Canada
- Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture SurgeryPivotal-lookingRecruiting
Jenna-Leigh WilsonAcademic, hospital or other
NCT06949826 · 100 participants (planned) · Start Apr 21, 2025 · Primary completion Mar 2027
Drug: Buprenorphine Transdermal System; Placebo Patch · For: Pain, Postoperative; Ankle Fracture Surgery; Opioid Use Disorder and 2 more
Sites: St Louis, Missouri
Senthil SadhasivamAcademic, hospital or other
NCT03923374 · 600 participants (planned) · Start Sep 15, 2018 · Primary completion Dec 30, 2026
Drug: Subutex / Buprenorphine · For: Opioid-use Disorder; Opioid Use, Unspecified; Buprenorphine Dependence
Sites: Pittsburgh, Pennsylvania
University of British ColumbiaAcademic, hospital or other
NCT05585229 · 10 participants (planned) · Start Oct 27, 2025 · Primary completion Aug 31, 2026
Drug: Psilocybin-assisted Psychotherapy · For: Opioid Dependence; Chronic Pain
Sites: Kelowna, Canada
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT04811014 · 250 participants (planned) · Start Apr 19, 2021 · Primary completion Aug 31, 2030
Drug: Buprenorphine, Naloxone Drug Combination · For: Opioid-use Disorder; Opioid Dependence; Opioid Overdose and 2 more
Sites: Houston, Texas
Inventage Lab., Inc.Industry
NCT05620940 · 40 participants (planned) · Start Sep 11, 2024 · Primary completion Dec 30, 2025
Drug: Vivitrol Injectable Product; IVL3004 and 1 more · For: Opioid Dependence; Alcohol Dependence; Multiple Sclerosis
Sites: Herston, Australia
- Pharmacokinetic Modeling of MethadoneRecruiting
University Hospital, MontpellierAcademic, hospital or other
NCT05490732 · 100 participants (planned) · Start Mar 23, 2024 · Primary completion Apr 1, 2025
Drug: Blood sampling · For: Toxicomania
Sites: Montpellier, France
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.